rs56064803
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1
The NM_021072.4(HCN1):βc.201_209delβ(p.Gly72_Gly74del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,529,748 control chromosomes in the GnomAD database, including 621 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.028 ( 87 hom., cov: 32)
Exomes π: 0.020 ( 534 hom. )
Consequence
HCN1
NM_021072.4 inframe_deletion
NM_021072.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.38
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_021072.4.
BP6
Variant 5-45695884-GCCGCCGCCA-G is Benign according to our data. Variant chr5-45695884-GCCGCCGCCA-G is described in ClinVar as [Benign]. Clinvar id is 95999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-45695884-GCCGCCGCCA-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCN1 | NM_021072.4 | c.201_209del | p.Gly72_Gly74del | inframe_deletion | 1/8 | ENST00000303230.6 | NP_066550.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCN1 | ENST00000303230.6 | c.201_209del | p.Gly72_Gly74del | inframe_deletion | 1/8 | 1 | NM_021072.4 | ENSP00000307342 | P2 | |
HCN1 | ENST00000634658.1 | c.201_209del | p.Gly72_Gly74del | inframe_deletion | 1/2 | 3 | ENSP00000489134 | |||
HCN1 | ENST00000673735.1 | c.201_209del | p.Gly72_Gly74del | inframe_deletion | 1/9 | ENSP00000501107 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0284 AC: 4277AN: 150482Hom.: 87 Cov.: 32
GnomAD3 genomes
AF:
AC:
4277
AN:
150482
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0198 AC: 2842AN: 143504Hom.: 140 AF XY: 0.0205 AC XY: 1633AN XY: 79598
GnomAD3 exomes
AF:
AC:
2842
AN:
143504
Hom.:
AF XY:
AC XY:
1633
AN XY:
79598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0204 AC: 28203AN: 1379162Hom.: 534 AF XY: 0.0205 AC XY: 14004AN XY: 681950
GnomAD4 exome
AF:
AC:
28203
AN:
1379162
Hom.:
AF XY:
AC XY:
14004
AN XY:
681950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0284 AC: 4280AN: 150586Hom.: 87 Cov.: 32 AF XY: 0.0264 AC XY: 1942AN XY: 73588
GnomAD4 genome
AF:
AC:
4280
AN:
150586
Hom.:
Cov.:
32
AF XY:
AC XY:
1942
AN XY:
73588
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
36
AN:
3400
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 08, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 02, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 12, 2013 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at